AnaptysBio Inc’s recent filing unveils that its CEO Faga Daniel unloaded Company’s shares for reported $64268.0 on Mar 25 ’24. In the deal valued at $21.42 per share,3,000 shares were sold. As a result of this transaction, Faga Daniel now holds 749,087 shares worth roughly $16.13 million.
Then, Faga Daniel sold 145,940 shares, generating $3,325,185 in total proceeds. Upon selling the shares at $22.78, the CEO now owns 752,087 shares.
Before that, LOUMEAU ERIC J sold 5,000 shares. AnaptysBio Inc shares valued at $125,000 were divested by the CHIEF LEGAL OFFICER at a price of $25.00 per share. As a result of the transaction, LOUMEAU ERIC J now holds 3,240 shares, worth roughly $69757.2.
Wedbush upgraded its AnaptysBio Inc [ANAB] rating to an Outperform from a a Neutral in a research note published on March 12, 2024; the price target was increased to $34 from $20. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late February with a ‘”a Buy”‘ rating. Stifel began covering ANAB with “Buy” recommendation on February 21, 2024. Piper Sandler started covering the stock on February 16, 2024. It rated ANAB as “an Overweight”.
Price Performance Review of ANAB
On Tuesday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock jump 4.16% to $21.53. Over the last five days, the stock has gained 3.31%. AnaptysBio Inc shares have risen nearly 0.51% since the year began. Nevertheless, the stocks have risen 0.56% over the past one year. While a 52-week high of $27.50 was reached on 02/26/24, a 52-week low of $13.36 was recorded on 04/03/24. SMA at 50 days reached $23.60, while 200 days put it at $20.02. A total of 0.42 million shares were traded, compared to the trading of 0.39 million shares in the previous session.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 20.67, which if violated will result in even more drops to 19.80. On the upside, there is a resistance level at 22.11. A further resistance level may holdings at 22.68. The Relative Strength Index (RSI) on the 14-day chart is 44.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.80%. Stochastics %K at 19.54% indicates the stock is a buying.
How much short interest is there in AnaptysBio Inc?
A steep rise in short interest was recorded in AnaptysBio Inc stocks on Mar 15, 2024, dropping by -0.37 million shares to a total of 4.14 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 4.51 million shares. There was a decline of -8.94%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 22.65% of the overall stock float, the days-to-cover ratio (short ratio) fell to 13.14.
